These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28350903)

  • 1. Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.
    Tsalik EL; Petzold E; Kreiswirth BN; Bonomo RA; Banerjee R; Lautenbach E; Evans SR; Hanson KE; Klausner JD; Patel R; ;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S41-S47. PubMed ID: 28350903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
    Manca C; Hill C; Hujer AM; Patel R; Evans SR; Bonomo RA; Kreiswirth BN;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S13-S17. PubMed ID: 28350898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
    Anderson DJ; Jenkins TC; Evans SR; Harris AD; Weinstein RA; Tamma PD; Han JH; Banerjee R; Patel R; Zaoutis T; Lautenbach E;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S36-S40. PubMed ID: 28350902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial resistance leadership group: open for business.
    Chambers HF; Bartlett JG; Bonomo RA; Chiou C; Cosgrove SE; Cross HR; Daum RS; Downing M; Evans SR; Knisely J; Kreiswirth BN; Lautenbach E; Mickley BS; Patel R; Pettigrew MM; Rodvold KA; Spellberg B; Fowler VG
    Clin Infect Dis; 2014 Jun; 58(11):1571-6. PubMed ID: 24610430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial sepsis : Diagnostics and calculated antibiotic therapy].
    Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Krüger WA; Mayer K; Pletz MW; Störzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
    Anaesthesist; 2017 Oct; 66(10):737-761. PubMed ID: 28980026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [STRATEGY OF ANTIBACTERIAL THERAPY OF SEPSIS. PART I].
    Shapoval SD; Savon IL; Martyniuk VB; Vasylevska LA; Yakunych AM; Maksimova OO; Sofilkanych MM
    Klin Khir; 2015 Jun; (6):62-6. PubMed ID: 26521472
    [No Abstract]   [Full Text] [Related]  

  • 7. New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance.
    Tsalik EL; Bonomo RA; Fowler VG
    Annu Rev Med; 2018 Jan; 69():379-394. PubMed ID: 29414265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostics as essential tools for containing antibacterial resistance.
    Okeke IN; Peeling RW; Goossens H; Auckenthaler R; Olmsted SS; de Lavison JF; Zimmer BL; Perkins MD; Nordqvist K
    Drug Resist Updat; 2011 Apr; 14(2):95-106. PubMed ID: 21398170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the treatment of musculoskeletal infections with molecular diagnostics.
    Tarkin IS; Dunman PM; Garvin KL
    Clin Orthop Relat Res; 2005 Aug; (437):83-8. PubMed ID: 16056030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
    Chambers HF; Cross HR; Evans SR; Kreiswirth BN; Fowler VG;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S3-S7. PubMed ID: 28350896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostics and Resistance Profiling of Bacterial Pathogens.
    Hornischer K; Häußler S
    Curr Top Microbiol Immunol; 2016; 398():89-102. PubMed ID: 27474081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial resistance--the clinical challenge.
    Finch R
    Clin Microbiol Infect; 2002; 8 Suppl 3():21-32; discussion 33-5. PubMed ID: 12519346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the microbiology laboratory in antimicrobial stewardship programs.
    Avdic E; Carroll KC
    Infect Dis Clin North Am; 2014 Jun; 28(2):215-35. PubMed ID: 24857389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerating global innovation to address antibacterial resistance: introducing CARB-X.
    Outterson K; Rex JH; Jinks T; Jackson P; Hallinan J; Karp S; Hung DT; Franceschi F; Merkeley T; Houchens C; Dixon DM; Kurilla MG; Aurigemma R; Larsen J
    Nat Rev Drug Discov; 2016 Sep; 15(9):589-590. PubMed ID: 27469032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time for a change: addressing R&D and commercialization challenges for antibacterials.
    Payne DJ; Miller LF; Findlay D; Anderson J; Marks L
    Philos Trans R Soc Lond B Biol Sci; 2015 Jun; 370(1670):20140086. PubMed ID: 25918443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time PCR as a diagnostic tool for bacterial diseases.
    Maurin M
    Expert Rev Mol Diagn; 2012 Sep; 12(7):731-54. PubMed ID: 23153240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial resistance: an emerging 'zoonosis'?
    Labro MT; Bryskier JM
    Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1441-61. PubMed ID: 25348154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Drug Resistance in Bacteria.
    Waclaw B
    Adv Exp Med Biol; 2016; 915():49-67. PubMed ID: 27193537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hierarchical nested trial design (HNTD) for demonstrating treatment efficacy of new antibacterial drugs in patient populations with emerging bacterial resistance.
    Huque MF; Valappil T; Soon GG
    Stat Med; 2014 Nov; 33(25):4321-36. PubMed ID: 24957660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.